Artificial chromosomes is an exciting technology which has developed rapidly since the late 1990s. HACs (human artificial chromosomes) are autonomous molecules that can function and segregate as normal chromosomes in human cells. The advantages of an artificial-chromosome-based system are 2-fold. First, HACs are an excellent research tool for investigating the requirements for normal chromosome structure and function during the cell cycle. They are important in defining the sequence requirements of functional chromosomes, and investigating the organization and composition of the chromatin. Secondly, HACs are useful gene-transfer vectors for expression studies in mammalian cells, with the capacity to incorporate large DNA segments encompassing genes and their regulatory elements. As episomes, they are stably maintained, leading to more reliable and prolonged transgene expression. HACs offer the possibility of long-term gene expression in human cells and the development of future somatic gene therapy.
Introduction
Over the last 8 years, the strategies for generating HACs (human artificial chromosomes) have encompassed several approaches [1] . In early studies, two models were established. The 'top-down' approach or TACF (telomere-associated chromosome fragmentation) involved modifying natural chromosomes into smaller defined minichromosomes in cultured cells. Following recombination and subsequent breakage between homologous sequences on the endogenous host chromosome and an incoming telomere containing the targeting vector, engineered minichromosomes as small as 450 kb in size in avian cells [2] have been generated. This approach has been important for studying the structure, sequence organization and size requirements of the human X and Y chromosomes [3, 4] . The 'bottom-up' or assembly approach has involved generating HACs in human cells by introducing defined chromosomal sequences as naked DNA including human telomeres, alpha satellite (alphoid) DNA and genomic fragments containing replication origins [1, 5, 6] . De novo HACs are generated following recombination and some amplification of the input DNA within the host cell. Together, the generation of minichromosomes and de novo HACs has identified alphoid DNA as the major sequence element of the centromere and determined the minimum size (approx. 70-100 kb) required for centromere function and stability [4] .
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regions of host chromosomes and modifying small human marker chromosomes (minichromosomes derived from naturally occurring chromosomes). The focus of this minireview, however, is to evaluate the requirements and function of de novo artificial chromosomes by the bottom-up/ assembly approach.
The requirements of de novo artificial chromosomes
The ideas for HAC formation stemmed from early studies on artificial chromosomes in yeast developed by Murray and Szostak [7] which were the basis of the first YAC (yeast artificial chromosome) libraries [8] . The essential elements that are necessary for YACs were based on the structure and function of normal yeast chromosomes. YACs required telomeres at the chromosome ends to maintain linearity, a sequence origin for faithful DNA replication and a centromere for appropriate segregation and stability during the cell cycle. HAC requirements are different in human cells. Approx. 1 kb of telomeric sequence is sufficient to generate a de novo telomere on a minichromosome by TACF; however, the first-generation de novo HACs that have been formed are circular, indicating that telomeres are dispensable [1] . Also, the identification of specific origins of replication is not essential for HAC formation as they are present every few tens of kilobases in any large stretch of genomic DNA. Work has largely focused on determining the sequences for HAC centromere function. The major sequence element at the human centromere is alphoid DNA which comprises a 170 bp monomer repeat unit arranged into larger arrays of HORs (higher-order repeats) spanning several megabases at most human centromeres. The kinetochore assembles at the centromere for attachment of the chromosome to the microtubules, and this ensures appropriate segregation through mitosis. CENPs (centromere proteins) localize to the kinetochore for functional centromeric activity, and CENP-A plays a key role in kinetochore assembly and recruitment of other factors for full kinetochore function [9] . However, studies involving the characterization of marker chromosomes have revealed other centromeres (known as neocentromeres) that do not contain alphoid DNA [10] . The formation of neocentromeres suggests that they are generated on the marker chromosomes by an epigenetic marker from within the cell, perhaps resulting from an early activation mechanism in centromere evolution. Irvine et al. [11] indicate that neocentromeres also bind CENP-A, albeit at reduced levels compared with normal centromeres containing alphoid DNA. The evolutionary organization of centromeric alphoid arrays generated higher levels of CENP-A, which is possibly required for the formation of more stable chromosomes.
De novo HACs have been generated in human cells following the introduction of BACs (bacterial artificial chromosomes) or PACs (P1-derived artificial chromosomes) containing large arrays of cloned or synthetic alphoid DNA repeats from chromosomes 5, 13/21, 14/22, 17, 18 and X [1] . The input DNA undergoes a process of recombination and amplification, forming large (1-10 Mb) circular molecules (usually at one or two copies per cell) which are mitotically stable in the absence of selection for at least 9 months in some cells [12] . To date, linear de novo artificial chromosomes have not routinely been stably developed, since the functional requirements for telomeres in a de novo HAC are not fully understood. However, the efficiency of de novo HAC formation and stability depends on the presence of a centromere protein B-binding sequence (CENP-B box) [13, 14] and, to some extent, on the chromosomal origin of the alphoid template and the longer length of the alphoid array (> 100 kb) [15] .
HAC gene expression vectors
HAC vectors have been used successfully for gene transfer and expression in human cells. These studies have focused on using well-known cell-culture models, including studies of the human HPRT1 (hypoxanthine guanine phosphoribosyltransferase 1) [16, 17] and the GCH1 (GTP cyclohydrolase 1) genes [18] . Two transfection approaches were used in these studies, yielding similar results. In the HPRT1 study, we introduced a single vector containing chromosome 17 alphoid DNA and the HPRT1 gene into human fibroblast (HT1080) cells containing the HPRT1 deficiency [17] . The vector was constructed in Escherichia coli following recombination between a 17 alphoid BAC and an HPRT1 PAC containing the entire HPRT1 genomic locus, generating a large stable HAC vector of 404 kb [19] . HACs containing the HPRT1 gene were generated which complemented the genetic deficiency [17] (Figure 1A ). In another strategy by Grimes et al. [16] , an alphoid PAC and an HPRT1 BAC were introduced simultaneously into HPRT1-deficient HT1080 cells by cotransfection, generating similar HPRT1-expressing HACs. Ikeno et al. [18] also used this approach to introduce an alphoid BAC and GCH1 BAC to generate GCH1-expressing HACs. From an analysis of DNA fibres prepared from the HPRT1 HAC-containing cells, we showed that the HAC structure contained alternating and different sized fragments of alphoid and HPRT1 DNA ( Figure 1B) . However, the HPRT1 expression from the HAC was not compromised by this arrangement. The mitotic stability did not seem to be affected either, with 98-99% of the HAC segregating correctly at each cell division. However, some studies have shown that size is an important factor that affects HAC segregation, with larger HACs being more stable than smaller HACs [20] . The same study suggested that the circular organization of the majority of HACs does not have a large effect on their stability [20] .
In other experiments supporting the role of HACs as gene vectors, the chromatin assembly on the HACs has been studied to determine the environment for gene expression [21, 22] . These studies included reacting HACs (only containing alphoid DNA) with specific antibodies against chromatin-associated histone H3 to detect the presence of euchromatin with the marker histone H3 dimethylated at lysine 4 (diMetH3K4) or heterochromatin with the marker histone H3 trimethylated at lysine 9 (triMetH3K9). In normal metaphase chromosomes, Sullivan and Karpen [23] observed that the euchromatic marker histone H3K4 is distributed along the length of the chromosome, concentrating in more gene-rich areas, but is barely detectable at the chromosome centromeres. However, analysis of chromosomal DNA fibres prepared from human cells showed that diMetH3K4 was detected at the centromere, yet was interspersed with CENP-A, indicating that this was a region of more 'open' chromatin and a transcriptionally permissive state. In comparison, triMetH3K9 was detected in pericentromeric regions flanking the core centromere and was consistent with the distribution of heterochromatin along the chromosome. In immunofluorescence studies of metaphase chromosomes prepared from HAC-containing cell lines, Grimes et al. [21] reported that alphoid-only HACs contained euchromatin, indicating the presence of a transcriptionally permissive state for gene expression. However, variable amounts of heterochromatin were present which correlated with HAC size, with small HACs containing less than large HACs. This raises the possibility that heterochromatin may not be an absolute requirement on some HACs. In another study, Nakashima et al. [22] investigated the chromatin state on HAC vectors containing marker genes on both arms flanking the alphoid DNA. They found that the formation of HACs and the correct assembly of chromatin requires centromeric alphoid DNA to be flanked by heterochromatin at least on one vector arm. A chromatin state which is transcriptionally permissive on either side of the centromeric alphoid DNA cannot support the formation of heterochromatin and leads to unstable HACs.
Challenges for HAC gene expression studies

Generation of new vectors
Studies in the field are now directed towards ways to efficiently incorporate genes into HACs for a wide range of expression studies in different cell systems. This will require reliable and rapid methods to generate these large transfer vectors. Manipulation of BAC and PAC vectors by conventional subcloning with restriction digestion and ligation [24] to generate constructs is useful for incorporating small DNA sequences and reporter genes, but is laborious and inefficient for incorporating large genomic segments owing to the size limitation of BACs and PACs following transformation into most E. coli strains. More recent systems based on recombination in vivo are more efficient, reliable and relatively quick to process. A popular method which has had good success rates for incorporating various DNA sequences into HAC vectors includes site-specific recombination at loxP sites on BACs and PACs catalysed by Cre recombinase from the E. coli bacteriophage P1 [25] . Kotzamanis et al. [26] have successfully used Red-mediated recombination utilizing the Red operon from bacteriophage lambda to join overlapping BACs containing Factor VIII and CFTR (cystic fibrosis transmembrane conductance regulator) genes into a single vector. They also used this method to construct a single vector containing alphoid DNA and the human HPRT1 gene which generated HPRT1-expressing HACs in human HT1080 cells [27] . Another novel method utilizes Tn5-bacterial-based DNA transposition to join two BACs. Modification of an alphoid BAC vector with transposaserecognition elements forms the template for recombination with any genomic BAC, allowing the generation of a single HAC vector [14] .
Delivery systems
To date, studies have focused on generating HACs in HT1080 cells since the efficiency of HAC formation is high. A major challenge is the delivery of HAC vectors into other cell types to enable gene-expression studies in different systems. Delivery of intact HAC DNA into human cells is essential for a high frequency of HAC formation in any cell type. Methods used for large DNA delivery include liposomemediated transfer, targeting to specific cell-surface receptors with an integrin peptide delivery system and adenoviralmediated delivery [1, 6] . Some of these methods are used in conjunction with condensing reagents such as poly-(ethyleneimine) for protecting large DNA from degradation [28] or in combination to enhance the delivery, for example using liposomes with the integrin peptide delivery system; however, they are generally inefficient for large DNA. One promising development for large DNA delivery is the HSV-1 (herpes simplex virus type 1) amplicon technology. HSV-1 has a large genome (152 kb) and the capacity to deliver large DNA following infection of a variety of cell types (dividing and non-dividing) with a minimum risk of toxicity. The major advance in this technology is that the replication competence of the HSV-1 has been eliminated by removing the requirements for viral replication and it is a helper-virus-free system [29] . Using this technology, efficiencies of up to 100% have been obtained following infectious delivery of large DNA as BACs or PACs into different mammalian cell types.
Establishing HACs in mammalian cells
HACs now offer the possibility to express large human transgenes in murine cells, and complement murine models of human genetic diseases. Establishing artificial vectors in murine cells will be important for complementary gene expression studies. In initial studies, we investigated the stability of human alphoid HACs (previously generated in human HT1080 cells) in murine cells following transfer by microcell fusion [30] . We established several murine cell lines containing HACs with human alphoid DNA and observed that the HACs bound CENP-C, indicating the presence of centromere activity. However, without selection, the HACs were lost rapidly (2-5%/day) from the cells, suggesting that human alphoid DNA in a HAC can only support partial centromere function in murine cells. Murine centromere sequences, such as minor and major satellite DNA, may therefore be required for full activity and mitotic stability in an artificial chromosome. Shen et al. [31] found that human Y-chromosome-derived minichromosomes were unstable in murine cells except for one minichromosome ST1 (4.5 Mb), which had acquired minor and major satellite DNA from the host cells. Only the minor satellite repeats on the ST1 minichromosome were functional, indicating that murine centromeric DNA was required for centromere function [32] . Further work, however, will be required to determine the exact sequence requirements and factors for full centromere function in murine cell lines.
Summary
De novo HACs are viable transfer vectors for gene-expression studies and can complement genetic deficiencies in human cells. Similar to normal chromosomes, these HACs contain regions of both euchromatin and heterochromatin and are therefore a transcriptionally permissive environment for gene expression. For efficient and stable de novo HAC formation, centromeric chromatin formed over alphoid DNA should probably be flanked at least unilaterally by heterochromatin.
The future direction of the field is to develop robust HAC gene-expression systems in other cell types, which will require reliable and fast methods for assembly of HAC gene vectors and highly efficient delivery systems. Generating artificial chromosomes in murine cells for human transgene studies will require determination of the chromosomal sequences that are essential for centromeric function in a de novo HAC.
